Uses
A new urinary metabolite of the human doping Metandienone (Methandrostenolone, M226000). This metabolite was reported to be detected in urine samples up to 19 days after administration of Metandienone.
Uses
17β-Hydroxymethyl-17α-methyl-18-norandrosta-1,4,13-trien-3-one is a new urinary labelled metabolite of the human doping Metandienone (Methandrostenolone, M226000). This metabolite was reported to be detected in urine samples up to 19 days after administration of Metandienone.
